Different Plaque Composition and Progression in Patients with Stable and Unstable Coronary Syndromes Evaluated by Cardiac CT

Table 2

Risk factor management at follow-up.

Risk factor management at follow-up	SAP	UAP/n-STEMI	value
Aspirin (%)	31 (97%)	15 (100%)	1
Clopidogrel (%)	19 (59%)	14 (93%)	0.02
Statins (%)	28 (88%)	15 (100%)	0.29
Beta-blockers (%)	19 (59%)	9 (60%)	0.97
ACE-inhibitors/AT2-antagonists (%)	15 (49%)	8 (53%)	0.68
Smoking			0.60
No (%)	7 (22%)	3 (20%)
Active (%)	6 (19%)	1 (7%)
Former (%)	19 (59%)	11 (73%)